(3,4-Difluorophenyl)-[2-(1-piperidylmethyl)phenyl]methanone, identified by its CAS number 898773-77-8, is a synthetic organic compound characterized by its complex structure that includes a ketone functional group and a piperidine moiety. This compound features a difluorophenyl group, which enhances its electronic properties and may influence its reactivity and biological activity. The presence of the piperidyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound is likely to exhibit moderate to high lipophilicity due to its aromatic rings, which can affect its solubility and permeability in biological systems. Additionally, the fluorine substituents can impart unique characteristics such as increased metabolic stability and altered binding affinity to receptors. Overall, this compound's structural features suggest potential applications in drug development, particularly in areas targeting central nervous system disorders or other therapeutic areas where piperidine derivatives are known to be effective.

(3,4-difluorophenyl)-[2-(1-piperidylmethyl)phenyl]methanone

898773-77-8: (3,4-Difluorophenyl)-[2-(1-piperidylmethyl)phenyl]methanone, identified by its CAS number 898773-77-8, is a synthetic organic compound characterized by its complex structure that includes a ketone functional group and a piperidine moiety. This compound features a difluorophenyl group, which enhances its electronic properties and may influence its reactivity and biological activity. The presence of the piperidyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound is likely to exhibit moderate to high lipophilicity due to its aromatic rings, which can affect its solubility and permeability in biological systems. Additionally, the fluorine substituents can impart unique characteristics such as increased metabolic stability and altered binding affinity to receptors. Overall, this compound's structural features suggest potential applications in drug development, particularly in areas targeting central nervous system disorders or other therapeutic areas where piperidine derivatives are known to be effective.

CAS 898773-77-8

(3,4-difluorophenyl)-[2-(1-piperidylmethyl)phenyl]methanone

3′,4′-difluoro-2-piperidinomethyl benzophenone

Ref: 10-F205211